Radiation therapy system maker TomoTherapy Inc. (TOMO), Wednesday reported a wider loss for the third quarter, reflecting mainly the absence of a tax benefit recorded in the third quarter of the previous year.
Net loss attributable to shareholders for the third quarter widened to $13.88 million or $0.27 per share from $12.95 million or $0.26 per share in the previous year.
On average, seven analysts polled by Thomson Reuters expected the company to report loss of $0.20 per share. Analysts' estimates typically exclude special items.
Total revenue for the quarter rose 26% to $34.38 million from $27.37 million last year, yet missed analysts revenue expectations of $40.28 million.
Total operating expenses for the quarter were $19.69 million, compared to $22.49 million in the earlier year.
Total other income for the quarter declined to $0.71 million from $1.49 million a year ago.
Income tax expense for the quarter was $0.26 million, compared to a tax benefit of $6.30 million last year.
For the nine-month period, net loss attributable to shareholders was $34.00 million or $0.67 per share, compared to $25.99 million or $0.52 per share in the same period of the previous year. Total revenue for the period declined 10% to $106.08 million from $118.29 million last year.
The company reported a revenue backlog of $140 million as of September 30, 2009. The backlog includes $21 million of equipment orders received during the third quarter of 2009, less $3 million removed from backlog due to a customer failing to make a scheduled payment.
Looking forward to the fourth quarter, the company expects loss per share in the range of $0.06 to $0.23 and revenues in the range of $50 million to $70 million. Analysts expect a loss of $0.14 per share on revenues of $48.82 million for the next quarter.
For the full year 2009, the company expects revenues in the range of $155 million to $175 million. Loss per share is currently expected to range from $0.73 to $0.90, compared to the previous guidance range of $0.65 to $0.90. Analysts expect a loss of $0.74 per share on revenues of $160.81 million for the full year.
TOMO closed Wednesday's regular trading at $3.39, down 0.44 or 11.49%, on a volume of 280K shares on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.